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Abstract
Purpose—We sought to examine the ethical, legal, and social implications (ELSI) literature 
research and scholarship types, topics, and contributing community fields of training as a first step 
to charting the broader ELSI community’s future priorities and goals.
Methods—We categorized 642 articles and book chapters meeting inclusion criteria for content 
in both human genetics or genomics and ethics or ELSI during a 5-year period (2003–2008) 
according to research and scholarship types, topics, and the area of advanced training of the first-
listed author. Research and scholarship type categories were developed and characterized through 
in-depth review of 95 randomly sampled publications from the larger group.
Results—There is a single dominant approach to ELSI, which focuses on ethical and other social 
issues “downstream” of advances in genomics, the contributors to which predominately have 
advanced training in medicine or science fields other than social science. A comparatively low 
percentage of publications primarily offer policy recommendations, and these are much more 
likely to be written by those with advanced training in law than is the case for the literature as a 
whole. Social science studies predominately employ qualitative methods and vary significantly 
with respect to the extent and types of recommendations offered. Two further types of ELSI 
research and scholarship offer alternative models for so-called “normative” work in this field.
Conclusion—Considering topics, training, and types of ELSI research and scholarship from the 
most recent past allows for a baseline perspective that is sorely needed in charting this field’s 
future course.
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The phrase “ethical, legal, and social implications” (ELSI) derives from the Ethical, Legal 
and Social Implications Research Program of the US National Institutes of Health’s National 
Human Genome Research Institute (NHGRI). However, the community of ELSI researchers, 
understood as those investigating issues at the intersection of socially relevant concerns and 
human genomics, is much wider than those researchers supported by the National Institutes 
of Health or even by international counterparts. Just as we would not want to understand 
what counts as genomics research in terms of funding sources, we should not limit the 
boundaries of the ELSI community artificially by conflating this maturing field of research 
and scholarship with a particular government program. Indeed, although most acknowledged 
funding for ELSI research is from the National Institutes of Health, only a little more than a 
third of ELSI publications acknowledge any funding (C. Morrissey and R.L. Walker, 
Funding and Forums for ELSI Reaserch, unpublished data).
Yet while the NHGRI has drawn upon the larger genomics community in putting forth its 
visions for the future of genomics research, including ELSI research, the wider ELSI 
community has not similarly engaged in a process of envisioning future ELSI research 
priorities and goals. With the February 2011 publication of the newest strategic vision for 
genomics research,1 it may be time for ELSI as a maturing field encompassing a broad and 
diverse community to take a look at itself in contributing to charting its future course. 
However, to complete this task, the field needs a robust understanding of the research and 
scholarship contributions and literature in its most recent past.
Our research investigated literature at the intersection of ethics or ELSI and human genetics 
or genomics published between 2003 and 2008, the 5-year period immediately preceding the 
start of our project. In this article, we present a detailed account of the different types of 
research and scholarship appearing at this intersection as well as the topics addressed and 
the fields in which publication first-listed authors had advanced training. Elsewhere, we 
report in detail on findings regarding funding sources and publication venues (C. Morrissey 
and R.L. Walker, Funding and Forums for ELSI Reaserch, unpublished data).
MATERIALS AND METHODS
We collected publications addressing the intersection of ethics specifically or ELSI more 
broadly and human genetics or genomics released within the 5-year period from 2003 to 
2008. In order to represent the research and scholarship of the wider ELSI community, we 
utilized multiple sources capturing (i) the work of people closely identified with the ELSI 
Research Program through the ELSI Archives (created by Case Western Reserve 
University’s Center for Genetic Research Ethics and Law), the Bio-Medical Ethics 
Reference Server (hosted by Stanford University’s Center for Integration of Research on 
Genetics and Ethics), and all other Centers for Excellence in ELSI Research web pages; (ii) 
research from more broadly medical, social, and other science researchers through PubMed 
and Web of Science; and (iii) the work of humanities researchers and scholars (in particular, 
book chapters) through the GenETHX database (hosted by the Bioethics Research Library at 
Georgetown University).
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The multiplicity of sources dictated some variation in the search strategies. A narrowly 
tailored Boolean search was used for PubMed, Web of Science, and GenETHX; a key-word 
search was used for the Bio-Medical Ethics Reference Server; all of the references from the 
Centers for Excellence in ELSI Research web pages were collected, and the ELSI Archives 
were searched by hand for relevant publications. Search terms included variants and 
combinations of the terms “ethics,” “morality,” “ELSI,” “genomics,” and “genetics.” 
Specific search strategies were developed with the help of health sciences research librarians 
at the authors’ home institution as well as from the Georgetown Bioethics Research Library. 
Although our publication collection strategy was inclusive in terms of diverse contributors to 
the ELSI literature, ELSI-relevant publications released during our 5-year period that did not 
employ the terms “ethics,” “morality,” or “ELSI” and were not included in the ELSI 
databases or web pages consulted are not represented in this study.
The flow chart in Figure 1 tracks the inclusion/exclusion processes, which generated the 
final group of 642 articles and book chapters from the initial group of 1,010 publications 
collected. All English-language publications addressing human genetics or genomics and 
ethics or other ELSI that were book chapters, research/scholarship articles, or other 
substantial contributions to the literature (e.g., commentaries and, infrequently, editorials) 
were included in the study. No topics were excluded except those that did not specifically 
address human genetics/genomics.
All 642 publications were classified according to topic addressed, field of advanced training 
of the first-listed author, and one of five research and scholarship types. Topics were 
developed using the session headings for the 2008 ELSI Congress, “Translating ELSI: 
Global Perspectives in Research on the Ethical, Legal, and Social Implications of Human 
Genome Research,” held during May 1–3 in Cleveland, Ohio. Additional topics were added, 
and others conflated as necessary to adequately reflect the literature. First-listed author field 
of advanced training was determined according to information either available in the 
publication itself or from an institutional or individual website associated with the author. 
The five types employed for organizing the literature were developed through an in-depth 
analysis of 95 randomly sampled publications from the larger group. The titles we chose to 
reflect these types are: social science study report, broader ELSI, ethics focus, other 
normative focus, and policy recommendation. The particular features of each type of 




Twenty-two topics, each accounting for between 1% and 9% of the ELSI literature, are listed 
in Table 1. Also listed in Table 1 are interactions with the research and scholarship types that 
we discuss below. The most common topic was not any particular subtopic within genetics 
or genomics, but rather genetics or genomics generally. Authors addressing this topic may 
have referred to “the new genomics” or broadly “advances in genomics.” This topic was 
added to those delineated by the 2008 ELSI Congress session headings in order to 
accommodate the literature in our study. Additional categories that were added are “other,” 
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which included topics as diverse as behavioral genetics, chimeras, and cancer genomics, and 
“other genomic research,” “other genetic testing,” and “other reproductive genetics,” which 
were necessary to capture either a general focus on genetic testing, research, or reproductive 
genetics or particular subjects falling under these broader headings that were not represented 
elsewhere in the list.
ELSI community
To identify fields of advanced training within the ELSI community as well as international 
representation within our study, we located institutional affiliations of first- (or sole-) listed 
authors as well as first- (or sole-) listed author advanced degrees. Advanced degrees were 
categorized according to the fields presented along the top of Table 2. The institutional 
affiliations of authors represented in our study indicate a transnational research community. 
Rounding to the nearest percentage, 67% of first authors had primary institutional 
affiliations in North America, 25% in Europe, and 3% each in Asia and Australasia. One 
percent of authors were international bodies. There were no publications in which the first-
listed author’s primary institutional affiliation was in Africa or Central America.
Table 2 organizes first-listed author field of training according to the research and 
scholarship types discussed in more detail below; however, total numbers for authors with 
advance degrees in each field is a simple sum of each column. The most prevalent fields of 
study were humanities (including theology) (28%); medicine (defined as all fields 
contributing to clinical care) (19%); social science (18%); basic, natural, or medical science 
(18%); and law (17%). A noteworthy proportion of first authors (20%) had advanced 
training in multiple fields; therefore, the total number of publications for all fields combined 
is greater than > 100%.
Types
Research and scholarship types to organize and enhance understanding of the ELSI work 
represented in our study were developed through an iterative process of in-depth review and 
analysis of 95 publications randomly sampled from the larger group. The types represent 
nexuses of methodological, conceptual, and practical or theoretical focuses within the 
publications. Type definitions, frequencies within the study as a whole, and sample quotes 
from publications representing each type appear in Table 3. Each type is presented in more 
detail below along with significant correlations with particular topics and first-listed author 
fields of training, which are summarized in Table 4.
Social science study report
The social science empirical methods study reports predominately rely on qualitative 
methods, but quantitative methods are also well represented. Supplementary Figure S1 
online details the methods reported in social science study report publications from our 
study. In terms of contributing community, it is not surprising that 41% of first-listed authors 
for these publications had advanced training in some area of social science. However, given 
the substantial methodological training required to conduct such a study, it may be more 
surprising that 35% of first-listed authors had advanced training in either medicine or a 
science other than social science and that 14% had advanced training in the humanities.
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The quote selected in Table 3 to illustrate the social science approach to ELSI research also 
illustrates the dominant topic within this type of publication, specifically genomic research 
and the public. Much of this research focused on the opinions of the public or of particular 
publics regarding specific areas of genomic science or of genomics generally. Although this 
topic was only 6% of the literature as a whole, it represented 22% of the social science 
publications.
Broad divergence with respect to whether and how social science study reports offer 
recommendations regarding the ELSI issues or topics addressed is particularly striking. In 
one report, the authors address morally salient issues regarding perceived quality of life in 
mothers of children with fragile X syndrome such as the positive impact of being a mother 
and stress associated with a lack of social support. Yet prescriptions offered by the authors 
were limited to projected future work, in particular that “in future studies with this 
population, researchers should emphasize the broader context of family well-being and 
adaptation to disability” (ref. 2, p. 172). In another report, the authors present a study of the 
views of at-risk children and parents about children’s roles in decision making about 
enrollment in genetic susceptibility research. On the basis of their findings, the group offers 
a proposal for an informed consent process that “(a) gives parents and children sufficient 
opportunity to ask questions of the researcher(s) and to communicate with one another, and 
(b) gives children the opportunity to exercise their right to refuse participation without 
parental influence” (ref. 3, p. 260).
Broader ELSI
This type of research and scholarship discusses or enumerates the ELSI issues related to 
some aspect of human genetics or genomics. In the sample quote in Table 3, genetic 
databases (the dominant topic for this publication type) present “new challenges” for law, 
ethics, and regulations. Generally speaking, the broader ELSI approach to research and 
scholarship can be characterized as “downstream” in so far as the concerns are seen as 
following developments in the science, technology, and/or the practice of genetics or 
genomics. In keeping with this characterization, topics that are significantly dominated by a 
broader ELSI approach include personalized health interventions (personalized medicine, 
pharmacogenomics, and nutrigenomics), the introduction and use of genetics/genomics 
within clinical practice, whole-genome sequencing or genome-wide association studies, and 
gene transfer research.
Within the broader ELSI publication, ELSI analysis itself may become a kind of inquiry to 
be “integrated” into a larger scientific endeavor. Hence, “The HapMap has been an exemplar 
of integrated and proactive ELSI analysis in genetic variation research” (ref. 4, p. S8). In 
other examples, ethical, legal, social, and other issues or concerns may all be noted 
separately but addressed interchangeably. So, for example, “these benefits [of prenatal 
genetic testing] are, however, tempered by a series of complex ethical, legal and social risks 
… These include: the risk of state intervention into private lives and the consequent loss in 
reproductive freedom; the risk of coercive testing emerging from medical paternalism; the 
risk of ambivalence in knowing whether prenatal testing should be offered for all conditions 
…” (ref. 5, p. 67).
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Although the broader ELSI publications sometimes specifically use the term “ethics” to 
identify the issues of concern (rather than either “ELSI” or “social” concerns), the ethical 
issues discussed can generally be characterized as morally salient practical problems, rather 
than issues arising within ethics as an area of study (such as would be a focus on how to 
understand respect for autonomy or whether to take a principle-based or virtue theory 
approach to justice). Hence, within the broader ELSI publication, “The Human Genome 
Project and related genetic research are exciting scientific quests that are also giving rise to 
significant ethical dilemmas and equity considerations … [such as] is research on human 
cloning ethical, privacy of genetic and medical records, genetic discrimination, implications 
for public health programmes, unequal access to new but expensive therapeutic interventions 
…” (ref. 6, p. 191).
In terms of contributing community, first-listed authors of the broader ELSI publications 
most commonly had advanced degrees in medical fields (30%) or a science other than social 
science (26%). In contrast, these fields are represented in 19% and 18%, respectively, of the 
publications overall. This finding may not be surprising, however, given that publications 
meeting the general description of broader ELSI may place emphasis on discussion of the 
genetics or genomics context or issue, addressing ethical or ELSI concerns only secondarily. 
Publications that simply raised ethical or ELSI issues but did not discuss them were not 
included in our study (see Figure 1); however, the extent to which publications focused on 
the ethical or ELSI issues in comparison with genomics or genetics ranged from a short 
discussion to the main focus of the publication.
Ethics focus
While broader ELSI publications take an issue, development, or practice in genetics or 
genomics as driving ethical or ELSI concerns, ethics-focus publications take as central an 
investigation within ethics. Very broadly, we might think of the ethics-focus publication as 
“ethics upstream,” with the ethical issues as perennial or primary, whereas genetics or 
genomics advances serve in different ways to help investigate, illuminate, or complicate 
these issues. In the sample quote in Table 3, the author is concerned to address how genetic 
interventions (including human enhancements) relate to theoretical concerns about justice. 
In contrast to the broader ELSI publications described above, the focus in this article is on 
theoretical concerns within ethics (the conceptual contours of different types of justice), 
while an issue related to advances in genomics research and/or practice (genetic 
intervention) serves as a context that can shed light on the theoretical debate.
The ethics-focus type includes both those publications that focus on specific ethical issues or 
topics and also those that focus on “meta” questions in ethics and bioethics, such as how to 
best address ethical issues arising in the context of genomics research or practices. For 
example, one author reflects on the value of a feminist approach to bioethics in the context 
of gene transfer writing, “I suggest that if traditional bioethics incorporates feminist 
understandings about gene transfer into its corpus, it has a better chance of serving the best 
interests of men and women equally” (ref. 7, p. 159).
Ethics-focus publications are most likely to be authored by individuals with advanced 
training in the humanities (61%), which is not surprising, given that ethics is traditionally a 
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branch of philosophy. However, not all humanities researchers and scholars writing this type 
of publication have degrees in philosophy; and there are also significant contributions from 
those with advanced training in law and the other sciences. Of particular interest is the 
striking fact that 28% of the ethics-focus publications address genetic enhancement, whereas 
this topic accounts for only 7% of publications overall.
Other normative focus
In contrast with ethics-focus publications, other normative-focus publications take some set 
of normative issues, questions, or concepts other than ethical as the primary focus. These 
concerns may be oriented, for example, to theology or religion, race theory, property rights 
including intellectual property, narrative identity, science norms, policy norms, or good 
governance. Although primarily adopting normative lenses other than ethics in their 
analyses, these publications hold a similar relationship to advances in genetics or genomics 
as the ethics-focus publications. Both approaches take as central their respective theoretical 
concerns or debates, whereas issues in genetics or genomics exemplify, illustrate, or 
complicate these types or sets of concerns.
The dominant topic within these publications was genomics generally, which is accounted 
for in large part by theological approaches, such as that in the sample quote in Table 3. 
However, publications taking up topics that were more specific, such as genetics/genomics 
and race or intellectual property, in which the issues are particularly amenable to framing as 
race theory or theoretical perspectives on ownership, respectively, were also common. Some 
authors working within these normative frameworks other than ethics addressed topics that 
also lend themselves easily to a broader ELSI analysis, such as pharmacogenomics or 
genetic testing. One pair of authors draw on “deliberative democracy and futures thinking” 
in order to offer an analysis of “how policy makers might manage the tensions and dilemmas 
they face by moving from an unstable, emergent policy arena [such as with 
pharmacogenetics] to a more stable one” (ref. 8, p. 533). Another author addresses genetic 
testing through the lens of narrative identity, writing, “This commentary responds to genetic 
testing of African ancestry through a series of personal narratives that reveal a complex, 
intimate, and individualized process of identity formation” (ref. 9, p. 142).
Not surprisingly, authors with advanced training in the humanities (38%) and law (23%) are 
the primary contributors to these normative publications primarily addressing frame-works 
other than ethics. While the humanities contributions are in part from those trained in 
theology, they also represent historians and philosophers, among others. Those writing from 
the perspective of law are contributing in large part to questions of good governance, 
appropriate models of intellectual property, and foundational questions in public policy. 
Another interesting set of contributors to this type of publication are authors trained in social 
sciences (19%) writing from a theoretical (rather than empirical) perspective, for example, in 
addressing norms of kinship or feminist theory.
Policy recommendation
We classified a publication as a policy recommendation if its primary purpose was to 
evaluate, recommend, or state genetics or genomics research or practice policy. A minority 
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of the policy recommendation publications are policy statements by institutional bodies 
regarding appropriate human genetics or genomics practices or research. For example, the 
Human Genome Organization Ethics Committee published a set of principles and 
recommendations regarding human genomic research in 2007.10 More common are policy 
recommendations put forward by individuals or coauthors in the context of an academic 
analysis or critique of a policy issue. The sample quote in Table 3 recommends a specific set 
of policies in response to a general policy issue (DNA patenting), and others offer analysis, 
critique, and/or recommendations regarding a particular policy or policy statement. For 
example, one group of authors offers a critique of the American College of Medical Genetics 
(ACMG) position on newborn screening, arguing that there were “limitations of the ACMG 
process” and that “programs are expanding rapidly, partly in response to the ACMG report, 
without the infrastructure in place to determine if the technology is bringing benefits or 
harms to children” (ref. 11, p. 1794).
Although publications serving primarily as policy recommendations or critiques are a small 
percentage of the ELSI literature overall, they dominate two particular topic areas: human 
subject protection and newborn screening. As we saw just above, there was a significant 
push for policies expanding newborn screening during the time period of this study, so it is 
perhaps not surprising that publications on the topic should primarily address policy 
considerations. Similarly, as human subject protection implies regulatory oversight, the 
focus on policy in these publications is also not surprising.
In terms of contributing community, it is interesting that while those with advanced training 
in the law dominate the publications that primarily serve as policy recommendations 
(accounting for 39% of the contributions to this literature), authors with legal training are 
roughly equally as likely to write broader ELSI, other normative, or policy 
recommendations. The versatility of legal training between these types of publications, 
combined with the dominance of a particular type of publication, is unique among the fields 
of training.
DISCUSSION
As recommendations regarding ethical, legal, social, and policy questions associated with 
human genomics research, practices, and technologies are widely recognized as, in some 
sense, the primary business of ELSI research and scholarship, it may be quite surprising that 
policy recommendations as we have understood them account for such a small percentage of 
the literature overall. This might seem especially the case, given the particular emphasis put 
on policy work in both the 2003 and 2011 NHGRI vision statements (ref. 1, pp. 208–209; 
ref. 12, p. 840). In this context, it is important to emphasize that many other publications in 
our study contained policy recommendations, even though these recommendations were not 
the primary focus of the publication. At the same time, even those publications that 
primarily critique, discuss, or make recommendations regarding policies may not “directly 
inform” actual policies. Policy recommendations that take place as part of a largely 
academic discussion, for example, may have little or no impact on policy development or 
change, although particularly influential or popularized approaches may be more successful 
in this regard (ref. 13, p. 3). However, it is the “translational” work informing policy that is 
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called for in the NHGRI statements and historically from the NHGRI and ELSI Research 
Program.15 In looking to the future, a continuing challenge will be determining how to 
position ELSI research relative to policy development.
In our study, we have understood policy recommendations as dealing specifically with laws, 
regulations, or institutional guidelines. While most ELSI publications have generally 
directive aims in the sense of offering suggestions or recommendations, not all of these are 
policy suggestions. Common within the ethics-focus type are prescriptions for moral action 
(e.g., regarding the “special moral problems in attempting to shape in advance the talents, 
preferences, and values of an individual with whom one expects to enter into a special kind 
of intimate relationship”) (ref. 15, p. 99). Another kind of recommendation addresses neither 
moral action nor policy, but rather suggests a certain theoretical organization of the world. 
For example, an article may argue in favor of “a conception of genetic privacy with a strong 
relational component” (ref. 16, p. 737). For discussions of the future of ELSI research and 
scholarship, it will be helpful to keep in mind, in addition to policy guidance, a role for both 
general moral and theoretical guidance.
In the context of ELSI work, social science empirical studies may be seen as generating the 
“data” upon which reliable policy recommendations should be built. Within bioethics, 
generally there have been calls for more empirical work, in part because of perceived 
shortcomings with nonempirical approaches to bioethics (ref. 17–20, ref. 21, pp. 37–40, ref. 
22). Indeed, the proportion of social science study reports found in our review coheres with 
the trend toward more inclusion of empirical work in bioethics generally.24–27 Yet, this 
increase in the proportion of empirical contributions, and arguments for more such 
contributions, have taken place without a clear resolution to the contested question of how 
empirical work should relate to, or inform, practical prescriptions and recommendations 
(including policy) (ref. 14, p. 11; ref. 27, p. 12; ref. 28, ref. 29) There is wide diversity 
within social science study reports in our study with respect to the strength and type of 
recommendations authors feel comfortable promoting regarding ethical, legal, social, or 
policy issues. As ELSI looks to the future, it should consider more critically and carefully, 
on one hand, what kinds of recommendations are best offered on the basis of what kinds of 
empirical claims and, on the other, what kinds of normative values already inform empirical 
work in ELSI.
In thinking toward the future, it is also important to recognize that the “downstream” model 
of raising and examining ELSI concerns arising with new or emerging genomic 
technologies, research, and practices has been the bread and butter of ELSI research. 
However, other models are available. Rather than focusing on the particular practical issues 
related to challenges in genomic science, we could focus on broader theoretical and 
normative concerns. Taking the NHGRI 2011 vision statement and specific ethics and other 
normative publications as comparison points, instead of looking at how to “design consent 
language that fully accounts for the broad utility that genomic data can offer …” (ref. 1, p. 
208), we might ask whether this broad utility could possibly cohere with the normative 
conditions under which informed consent is possible at all;30 or we might ask what fairness 
means in the context of genomic medicine32 instead of how to “ensure fair access to 
genomic medicine” (ref. 1, p. 210); or we could inquire how genomic medicine itself 
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reinscribes race concepts as normative33 rather than how race relates to the “biology of 
disease” (ref. 1, p. 210). Meaningful answers to these deeper normative questions may 
ultimately have the greatest practical impact by helping to define the very parameters of 
useful action-guiding questions.
The inclusive understanding of ELSI literature and scholarship and the subsequent potential 
for engagement of the wider ELSI community is a strength of our study; however, a 
limitation is that we have not captured ELSI research and scholarship that either did not 
employ the search terms we used or did not appear in any of the other databases or websites 
that we consulted. Furthermore, we do not present a historical analysis of ELSI work, but 
rather a snapshot of the most recent ELSI work in the 5-year period prior to the start of our 
project. Some of the more common topics in our study no doubt reflect particular perceived 
ELSI challenges related to burgeoning research areas or related practices within genomics 
(e.g., increased development of biorepositories), whereas some of the lower-frequency topics 
represent either topics that had not been perceived to be of high salience for genomic science 
but currently are (e.g., return of results and whole-genome sequencing) or topics that were 
previously of high significance but, by the study period, were waning in terms of genomic 
research priorities (e.g., gene transfer research).
Yet, even this snapshot look at a feature of the ELSI literature as changeable as prevalent 
topics of inquiry can be highly informative, in particular in conjunction with other features 
of the literature and information about the contributing community. For example, as we saw, 
reflection on genomics generally is the most common ELSI topic. Although this topic might 
be dismissed as overly broad by those working in the genome sciences, it also correlates 
with publications, perhaps authored by a philosopher, theologian, or lawyer, specifically 
concerned with investigating foundational normative questions within ethics or other 
domains of normative inquiry. The flip side of addressing genomics generally while focusing 
on foundational normative questions is arguably a broad focus on “societal” or “ethical” 
issues while offering a focused consideration of a particular topic within genome science 
research, clinical practices, or technologies such as is a likely contribution to the ELSI 
literature from a genome scientist, biostatistician, or genetic counselor.
Put this way, ELSI looks like a community divided. But we know from the information 
gathered through our study that there is no clean breakdown of topics, training, and types of 
research and scholarship. ELSI is a field inhabited by authors with multiple advanced 
degrees and cross-training, who may engage in out-of-the-box thinking, and are perfectly 
willing to work on topics and projects that are of intellectual interest but not at the top of 
anyone’s funding priorities (such as genetic enhancement). Despite clear trends and 
correlations documented by our investigation, it is no more the case that all those writing 
about theoretical issues in ethics are philosophers than it is true that all genome scientists are 
addressing ethical issues as only of secondary interest. Similarly, while so-called 
“normative” work in ELSI is frequently an inquiry into the ethical “implications” of a 
particular advance in genomics, or, less frequently, an investigation of the appropriate 
conceptualization of a theoretical construct within ethics, it may also be exemplified by a 
social scientist working in kinship theory or a science studies PhD investigating the norms of 
social science. These opportunities to “buck the trends” in ELSI that are evident from a look 
Walker and Morrissey Page 10













at the field’s most recent past may show as much, or more, about the potentiality of ELSI’s 
future as the strong imprinteur of certain research and scholarship types and significant 
correlations with topics and fields of training that we have documented.
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Figure 1. Identification of publications used in this study
ELSI, ethical, legal, and social implications.
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Table 1
Dominant publication types for each ELSI topic
Topic N = 642 % Total
Dominant
type % Topic
Genomics, general 58 9% Other normative 40%
Biorepository 49 8% Broader ELSI 55%
Genetics and race 45 7% Other normative 47%
Genetic enhancement 44 7% Ethics 66%
Genomic research and the public 40 6% Empirical 60%
Intellectual property 38 6% Other normative 50%
Personalized health interventions 29 5% Broader ELSI 62%
Genomics and clinical practice 29 5% Broader ELSI 62%
Human subject protection 24 4% Policy 38%
Informed consent 24 4% Empirical 38%
Broader ELSI 38%
Prenatal testing 18 3% Empirical 44%
Return of research results 15 2% Broader ELSI 47%
Gene transfer research 14 2% Broader ELSI 71%
GWAS or whole-genome sequencing 13 2% Broader ELSI 69%
Genomic research in native communities 13 2% Other normative 54%
Genomics and health disparities 12 2% Broader ELSI 42%
Newborn screening 9 1% Policy 56%
Genetic counseling 9 1% Broader ELSI 55%
Empirical 45%
Other genomic research 49 8% Broader ELSI 45%
Other genetic testing 46 7% Broader ELSI 50%
Other reproductive genetics 24 4% Broader ELSI 33%
Other normative 33%
Other 40 6% Broader ELSI 48%
ELSI, ethical, legal, and social implications; GWAS, genome-wide association study.
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Table 3
ELSI type definitions, frequencies, and sample quotes
Type Definition No. % Sample quote
Social science study 
report
Uses social science empirical methods to 
examine an ethics-related, ELSI, or 
otherwise morally salient issue in genetics 
or genomics.
108 17% “Objectives: We explored the opinions of 40 Black 
Americans regarding: (i) what they thought most 
blacks and whites believe about genetic causes for 
perceived race differences in human traits, and (ii) 
the impact of genetic science on them, their families, 
and black people.
Methods: We conducted in-depth telephone 
interviews with 40 self-identified Black men and 
women.”33
Broader ELSI Science, public health, or clinical focus 
with at least some discussion of ethical 
and/or ELSI issues or a review or 
discussion of the ethical or ELSI issues 
related to some area of genetics or 
genomics.
239 37% “The field of mental health offers a valuable context 
in which to examine new challenges presented by 
human genetic research databases to the legal, 
ethical, and regulatory types for human genetic 
research.”34
Ethics focus Examines an issue within ethics in which 
genetics or genomics serves to exemplify, 
illustrate, or complicate this ethics 
concept, problem, or question.
102 16% “This paper explores some of the challenges raised 
by human genetic interventions for debates about 
distributive justice, focusing on the challenges that 
face prioritarian theories of justice … Also examined 
are the implications of germ-line genetic 
enhancements for intergenerational justice … ”35
Other normative focus A specific normative focus other than 
ethics (such as narrative identity, race 
theory, religion/ theology, science norms, 
or intellectual property) is the primary 
focus.
127 20% “I… argue that a major contribution of theology to 
ethical reflection on genetic research would be 
through discussion of ways of reading, transmitting, 
and interpreting texts.”36
Policy recommendation Primarily an evaluation, recommendation, 
or statement of genetics or genomics 
research or practice policy (law, 
regulation, or guideline).
66 10% “[This paper] argues that, all things considered, the 
benefits of patenting DNA outweigh the harms, 
although societies should adopt policies designed to 
prevent or mitigate the harms associated with 
patenting. Some of these policies include …” (ref. 
37, p. 181)
ELSI, ethical, legal, and social implications
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